StonvexLoading…
StonvexStonvexStonvexCore line items from MTSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-03 | Annual 2024 2024-09-27 | Annual 2023 2023-09-29 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $967.26M | $729.58M | $648.41M | $675.17M |
Operating Income | $129.65M | $73.67M | $107.40M | $132.67M |
Net Income | $-54.21M | $76.86M | $91.58M | $439.95M |
EPS (Diluted) | $-0.73 | $1.04 | $1.28 | $6.18 |
Total Assets | $2.10B | $1.76B | $1.55B | $1.57B |
Total Liabilities | $776.26M | $629.30M | $605.64M | $729.07M |
Cash & Equivalents | $112.14M | $146.81M | $173.95M | $119.95M |
Free Cash Flow OCF − CapEx | $192.82M | $140.20M | $142.22M | $150.47M |
Shares Outstanding | 74.48M | 72.20M | 70.99M | 70.00M |